MRVI Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $7.90

P/E (TTM) -15.2

EPS (TTM) $-0.52

Ricavi (TTM) $209M

ROE (TTM) -32.9%

D/E Debito/Patrimonio (MRQ) 0.7

Intervallo 52 sett. $3–$9

MRVI Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Maravai LifeSciences Holdings, Inc. - Class A common stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaLife Sciences Tools & Services dipendenti415 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$186M

2019-12-31 → 2025-12-31

EPS$-0.90

2019-12-31 → 2025-12-31

Flusso di cassa libero$-71M

2021-12-31 → 2025-12-31

Margine netto-37.1%

2021-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	Tendenza 5 anni	MRVI	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)		-15.2media 5 anni ≈-5.4	≈-5.4	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	MRVI	media 5 anni	Mediana dei peer	Verdetto
Margine lordo (TTM)	34.9%	·	50.6%	Debole
Margine Operativo (TTM)	-56.1%media 5 anni ≈-72.6%	≈-72.6%	-0.30%	Debole
EBITDA Margin (Margine EBITDA)	-115.9%media 5 anni ≈-72.6%	≈-72.6%	-0.20%	Debole
Margine ante imposte (TTM)	-65.4%media 5 anni ≈-4.5%	≈-4.5%	0.17%	Debole
Margine di Profitto Netto (TTM)	-37.1%media 5 anni ≈-55.8%	≈-55.8%	-1.1%	Debole
ROA (TTM)	-10.3%media 5 anni ≈-11.2%	≈-11.2%	-2.7%	Debole
ROE (TTM)	-32.9%media 5 anni ≈-38.9%	≈-38.9%	-3.3%	Debole
ROIC	-41.9%media 5 anni ≈-26.3%	≈-26.3%	-4.4%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	MRVI	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.7media 5 anni ≈1.2	≈1.2	0.7	In linea
Rapporto corrente (MRQ)	4.1media 5 anni ≈7.4	≈7.4	3.4	Liquidità elevata
Quick Ratio	5.4media 5 anni ≈6.3	≈6.3	2.3	Liquidità elevata
Debito a lungo termine / Patrimonio netto (MRQ)	0.7media 5 anni ≈1.2	≈1.2	0.7	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	MRVI	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-28.3%media 5 anni ≈-35.3%	≈-35.3%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	-40.5%media 5 anni ≈-23.8%	≈-23.8%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	-8.2%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	MRVI	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.90media 5 anni ≈$-0.95	≈$-0.95	·	·
Revenue / Share (Ricavi / Azione)	$1.29media 5 anni ≈$1.79	≈$1.79	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.40media 5 anni ≈$0.20	≈$0.20	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	MRVI	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.2media 5 anni ≈0.2	≈0.2	0.4	Debole
Inventory Turnover (Rotazione delle scorte)	3.4media 5 anni ≈3.2	≈3.2	3.8	In linea
Receivables Turnover (Rotazione dei crediti)	5.8media 5 anni ≈5.5	≈5.5	5.9	In linea
Revenue / Employee (Ricavi / Dipendente)	≈$447.6K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 33.9%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 11, 2026	$-0.02	$-0.04	54.6%
31 Marzo 2026	Mag 11, 2026	$0.01	$-0.05	120.8%
31 Dicembre 2025		$-0.04	$-0.07	44.7%
30 Settembre 2025		$-0.08	$-0.08	4.0%
30 Giugno 2025		$-0.08	$-0.07	-10.7%
31 Marzo 2025		$-0.08	$-0.07	-9.7%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 18

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue	$186M	$259M	$289M	$883M	$799M	$284M	$143M
Cost of Revenue	$152M	$151M	$149M	$169M	$141M	$80M	$67M
Gross Profit	$34M	$108M	$140M	·	·	·	·
R&D Expense	$17M	$19M	$17M	$18M	$15M	$9M	$4M
SG&A Expense	$145M	$162M	$151M	$129M	$100M	$94M	$48M
Operating Expenses	$249M	$344M	$172M	$309M	$245M	$164M	$119M
Operating Income	$-215M	$-236M	$-32M	$574M	$555M	$120M	$24M
Interest Expense	·	·	$46M	$20M	$30M	$31M	$30M
Interest Income	$11M	$27M	$28M	$2M	$0	$0	·
Other Non-op	$-4M	$-2M	$-1M	$-358.0K	$279.0K	$126.0K	$118.0K
Pretax Income	$-235M	$-261M	$618M	$551M	$531M	$82M	$-6M
Income Tax	$-4M	$-2M	$756M	$61M	$62M	$3M	$-652.0K
Net Income	$-131M	$-145M	$-119M	$220M	$182M	$89M	$-4M
EPS (Basic)	$-0.90	$-1.05	$-0.90	$1.67	$1.59	$7.43	$-0.03
EPS (Diluted)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	$-0.03
Shares (Basic)	144,360,000	137,906,000	131,919,000	131,545,000	114,791,000	10,351,000	253,917,000
Shares (Diluted)	144,360,000	137,906,000	131,919,000	255,323,000	257,803,000	28,908,000	253,917,000
EBITDA	$-215M	$-236M	$-32M	$574M	$555M	·	·

Stato Patrimoniale 25

Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$217M	$322M	$575M	$632M	$551M	$236M	·
Receivables	$25M	$39M	$55M	$139M	$118M	$51M	·
Inventory	$40M	$50M	$51M	$43M	$52M	$33M	·
Prepaid Expense	$13M	$18M	$19M	$26M	$20M	$11M	·
Current Assets	$296M	$429M	$700M	$848M	$740M	$332M	·
PP&E (Net)	$151M	$164M	$163M	$53M	$46M	$101M	·
Accum. Depreciation	$68M	$53M	$32M	$20M	$13M	$11M	·
Goodwill	$129M	$160M	$326M	$284M	$153M	$224M	·
Intangibles	$152M	$195M	$221M	$217M	$118M	$178M	·
Other Non-current Assets	$42M	$60M	$78M	$116M	$53M	$4M	·
Total Assets	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·
Accounts Payable	$3M	$12M	·	$6M	$8M	$8M	·
Accrued Liabilities	$37M	$40M	$60M	$53M	$35M	$39M	·
Current Liabilities	$45M	$57M	$87M	$110M	$94M	$131M	·
Capital Leases	$34M	$41M	$48M	$52M	$41M	$56M	·
Deferred Tax	·	$11.0K	·	$0	$0	$9M	·
Other Non-current Liabilities	$36M	$52M	$59M	$69M	$41M	$2M	·
Total Liabilities	$398M	$431M	$698M	$1.38B	$1.37B	$1.12B	·
Long-term Debt	$292M	$296M	$524M	$527M	$531M	$535M	·
Total Debt	$292M	$296M	$524M	$527M	$531M	·	·
Paid-in Capital	$199M	$182M	$129M	$138M	$128M	$85M	·
Retained Earnings	$10M	$141M	$286M	$405M	$185M	$854.0K	·
AOCI	$524.0K	$0	·	·	$0	$-44.0K	·
Stockholders' Equity	$212M	$325M	$417M	$545M	$315M	$89M	·
Liabilities + Equity	$771M	$1.01B	$1.49B	$2.28B	$1.92B	$1.27B	·

Flusso di cassa 16

Metrica	2025	2024	2023	2022	2021	2020	2019
Stock-based Comp	$30M	$49M	$35M	$19M	$10M	$25M	$2M
Deferred Tax	$-20.0K	$11.0K	$755M	$42M	$47M	$-5M	$-1M
Amort. of Intangibles	$28M	$28M	$27M	$24M	$18M	$20M	$20M
Restructuring	$18M	$-1M	$6M	$0	$0	·	·
Operating Cash Flow	$-58M	$7M	$126M	$536M	$369M	$152M	$24M
CapEx	$13M	$30M	$66M	$17M	$15M	$25M	$17M
Investing Cash Flow	$-31M	$-24M	$-122M	$-268M	$106M	$6M	$-17M
Debt Issued	·	$953.0K	$0	$8M	$0	$609M	$0
Net Debt Issued	$-5M	$-233M	$-5M	$-5M	$-6M	·	·
Stock Repurchased	·	·	·	$0	$0	$34M	$0
Net Stock Activity	·	·	·	$0	$0	·	·
Financing Cash Flow	$-16M	$-236M	$-61M	$-187M	$-159M	$53M	$-4M
Net Change in Cash	$-106M	$-253M	$-57M	$81M	$315M	$211M	$3M
Taxes Paid	$-555.0K	$670.0K	$-3M	$23M	$22M	·	·
Free Cash Flow	$-71M	$-22M	$61M	$519M	$354M	·	·
Levered FCF	·	·	$71M	$501M	$327M	·	·

Redditività 8

Metrica	2025	2024	2023	2022	2021	2020	2019
Gross Margin	18.3%	·	·	·	·	·	·
Operating Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
Net Margin	-70.4%	-55.9%	-41.2%	24.9%	22.8%	·	·
Pretax Margin	-126.5%	-100.9%	213.8%	62.5%	66.4%	·	·
EBITDA Margin	-115.9%	-90.9%	-10.9%	65.0%	69.4%	·	·
ROA	-14.7%	-12.7%	-6.3%	10.5%	11.4%	·	·
ROE	-48.6%	-43.2%	-24.8%	51.2%	90.1%	·	·
ROIC	-41.9%	-37.7%	0.75%	47.6%	58.0%	·	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020	2019
Current Ratio	6.6	7.5	8.0	7.7	7.9	·	·
Quick Ratio	5.4	6.3	7.2	7.0	7.1	·	·
Debt / Equity	1.4	0.9	1.3	1.0	1.7	·	·
LT Debt / Equity	1.3	0.9	1.2	1.0	1.7	·	·
Interest Coverage	·	·	-0.7	28.1	18.3	·	·

Efficienza 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Asset Turnover	0.2	0.2	0.2	0.4	0.5	·	·
Inventory Turnover	3.4	3.0	3.1	3.6	3.3	·	·
Receivables Turnover	5.8	7.7	3.0	6.9	9.5	·	·

Per Azione 3

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue / Share	$1.29	$1.88	$2.19	$3.46	$3.10	·	·
Cash Flow / Share	$-0.40	$0.05	$0.96	$2.10	$1.43	·	·
EPS (TTM)	$-0.90	$-1.05	$-0.90	$1.67	$1.56	$2.36	·

Tassi di Crescita 5

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	-28.3%	-10.3%	-67.3%	10.5%	181.3%	·	·
Revenue CAGR 3Y	-40.5%	-31.3%	0.57%	·	·	·	·
Revenue CAGR 5Y	-8.2%	·	·	·	·	·	·
EPS YoY	·	·	·	7.0%	-33.9%	·	·
Net Income YoY	·	·	·	21.0%	104.6%	·	·

Valutazione (TTM) 4

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$186M	$259M	$289M	$883M	$799M	$284M	·
Net Income TTM	$-131M	$-145M	$-119M	$220M	$182M	$89M	·
P/E	-3.6	-5.2	-7.3	8.6	26.9	11.9	·
Earnings Yield	-27.7%	-19.3%	-13.7%	11.7%	3.7%	8.4%	·

Conto Economico 18

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$51M	$66M	$50M	$42M	$47M	$47M	$57M	$69M	$69M	$64M	$74M	$67M	$69M	$79M	$205M	$191M
Cost of Revenue	$31M	$32M	$37M	$36M	$40M	$39M	$37M	$37M	$39M	$38M	$35M	$37M	$43M	$34M	$53M	$38M
Gross Profit	$21M	$34M	$13M	$6M	$8M	$8M	$19M	$32M	·	·	·	·	·	·	·	·
R&D Expense	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$4M	$4M	$5M	$5M
SG&A Expense	$32M	$29M	$32M	$35M	$39M	$40M	$41M	$39M	$41M	$41M	$38M	$39M	$35M	$39M	$37M	$31M
Operating Expenses	$36M	$36M	$-7M	$47M	$74M	$57M	$-20M	$198M	$83M	$83M	$-67M	$82M	$81M	$76M	$95M	$74M
Operating Income	$-15M	$-2M	$-59M	$-41M	$-66M	$-49M	$-38M	$-166M	$-13M	$-19M	$-7M	$-15M	$-12M	$3M	$109M	$117M
Interest Expense	·	·	·	·	·	·	·	$14M	$12M	$11M	·	$12M	$7M	$12M	·	$3M
Interest Income	$1M	$2M	$2M	$3M	$3M	$3M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$2M	$0
Other Non-op	$-52.0K	$-494.0K	$-43.0K	$-71.0K	$-4M	$24.0K	$43.0K	$72.0K	$-3M	$106.0K	$49.0K	$66.0K	$-2M	$168.0K	$914.0K	$-4.0K
Pretax Income	$-22M	$-7M	$-63M	$-45M	$-74M	$-53M	$-46M	$-172M	$-21M	$-22M	$656M	$-21M	$-13M	$-5M	$96M	$114M
Income Tax	$-171.0K	$-151.0K	$6.0K	$-92.0K	$-4M	$162.0K	$-7.0K	$311.0K	$-2M	$271.0K	$766M	$-5M	$-1M	$-3M	$8M	$14M
Net Income	$-12M	$-4M	$-36M	$-26M	$-40M	$-30M	$-26M	$-97M	$-10M	$-12M	$-106M	$-6M	$-7M	$-67.0K	$38M	$44M
EPS (Basic)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.28	$0.34
EPS (Diluted)	$-0.08	$-0.02	$-0.24	$-0.18	$-0.27	$-0.21	$-0.21	$-0.68	$-0.07	$-0.09	$-0.80	$-0.05	$-0.05	$0.00	$0.30	$0.34
Shares (Basic)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,540,000
Shares (Diluted)	147,996,000	146,426,000	·	144,683,000	144,236,000	143,425,000	·	141,555,000	135,842,000	132,333,000	·	131,930,000	131,864,000	131,739,000	·	131,651,000
EBITDA	$-15M	$-2M	·	$-41M	$-66M	$-49M	·	$-169M	$-10M	$-19M	·	$-15M	$-12M	$3M	·	$117M

Stato Patrimoniale 25

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$70M	$166M	$217M	$244M	$270M	$285M	$322M	$578M	$573M	$562M	·	$580M	$580M	$628M	·	$617M
Receivables	$31M	$33M	$25M	$23M	$28M	$28M	$39M	$29M	$39M	$37M	·	$46M	$49M	$56M	·	$114M
Inventory	$41M	$40M	$40M	$45M	$47M	$50M	$50M	$50M	$49M	$50M	·	$49M	$47M	$55M	·	$62M
Prepaid Expense	$13M	$12M	$13M	$14M	$15M	$13M	$18M	$22M	$17M	$17M	·	$23M	$23M	$26M	·	$23M
Current Assets	$156M	$252M	$296M	$326M	$360M	$376M	$429M	$679M	$685M	$668M	·	$701M	$699M	$766M	·	$836M
PP&E (Net)	·	·	$151M	·	·	·	$164M	·	·	·	·	·	·	·	·	$48M
Accum. Depreciation	·	·	$68M	·	·	·	$53M	·	·	·	·	·	·	·	·	·
Goodwill	$129M	$129M	$129M	$129M	$129M	$160M	$160M	$172M	$326M	$326M	·	$326M	$326M	$327M	·	$284M
Intangibles	$138M	$145M	$152M	$186M	$193M	$200M	$195M	$202M	$207M	$214M	·	$228M	$235M	$242M	·	$223M
Other Non-current Assets	$38M	$40M	$42M	$49M	$52M	$58M	$60M	$61M	$63M	$75M	·	$86M	$93M	$127M	·	$87M
Total Assets	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B
Accounts Payable	$7M	$9M	$3M	$8M	$12M	$10M	$12M	·	·	·	·	·	·	$5M	·	$9M
Accrued Liabilities	$30M	$29M	$37M	$48M	$50M	$45M	$40M	$38M	$41M	$35M	·	$56M	$50M	$70M	·	$60M
Current Liabilities	$38M	$43M	$45M	$62M	$70M	$63M	$57M	$63M	$69M	$59M	·	$78M	$75M	$125M	·	$116M
Capital Leases	·	·	$34M	$36M	$38M	·	$41M	·	·	·	·	$50M	$52M	$54M	·	$44M
Deferred Tax	·	·	·	·	$2M	$2M	·	·	·	·	·	$7M	$9M	$9M	·	·
Other Non-current Liabilities	$34M	$36M	$36M	$38M	$38M	$44M	$52M	$54M	$54M	$59M	·	$65M	$63M	$66M	·	$58M
Total Liabilities	$248M	$344M	$398M	$417M	$429M	$429M	$431M	$665M	$671M	$667M	·	$1.38B	$1.37B	$1.41B	·	$1.41B
Long-term Debt	$147M	$241M	$292M	$293M	$294M	$295M	$296M	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Total Debt	$147M	$241M	·	$293M	$294M	$295M	·	$522M	$523M	$523M	·	$525M	$526M	$527M	·	$528M
Paid-in Capital	$208M	$202M	$199M	$197M	$191M	$187M	$182M	$176M	$168M	$134M	·	$125M	$120M	$114M	·	$134M
Retained Earnings	$-6M	$6M	$10M	$46M	$71M	$111M	$141M	$167M	$266M	$274M	·	$392M	$398M	$405M	·	$367M
AOCI	$459.0K	$466.0K	$524.0K	$579.0K	$574.0K	$324.0K	$0	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$205M	$212M	$212M	$245M	$266M	$301M	$325M	$345M	$437M	$411M	·	$519M	$521M	$522M	·	$504M
Liabilities + Equity	$604M	$713M	$771M	$849M	$897M	$960M	$1.01B	$1.28B	$1.45B	$1.44B	·	$2.27B	$2.26B	$2.32B	·	$2.25B

Flusso di cassa 14

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$10M	$7M	$4M	$9M	$7M	$10M	$11M	$13M	$14M	$12M	$9M	$10M	$9M	$6M	$6M	$5M
Deferred Tax	·	·	·	·	·	·	$11.0K	$0	$0	$0	$765M	$-6M	$-3M	$-2M	$7M	$9M
Amort. of Intangibles	$6M	$6M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$7M	$6M	$6M
Restructuring	$-33.0K	$3M	$10M	$7M	$0	$0	$6.0K	$-4.0K	$-4.0K	$-1M	$6M	$0	$0	$0	·	·
Operating Cash Flow	$4M	$9M	$-23M	$-15M	$-10M	$-9M	$-15M	$13M	$17M	$-8M	$8M	$14M	$19M	$85M	$99M	$110M
CapEx	$370.0K	$4M	$2M	$3M	$3M	$5M	$6M	$9M	$10M	$6M	$17M	$16M	$25M	$8M	$6M	$6M
Investing Cash Flow	$-370.0K	$-4M	$-2M	$-3M	$-3M	$-23M	$-5M	$-9M	$-6M	$-4M	$-13M	$-16M	$-24M	$-70M	$-19M	$-6M
Debt Issued	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	$0	$0
Net Debt Issued	·	$-51M	·	·	·	$-1M	·	·	·	$-1M	·	·	·	$-1M	·	·
Financing Cash Flow	$-99M	$-55M	$-2M	$-8M	$-2M	$-5M	$-236M	$809.0K	$228.0K	$-560.0K	$470.0K	$783.0K	$-43M	$-19M	$-66M	$-37M
Net Change in Cash	$-95M	$-51M	$-27M	$-26M	$-15M	$-37M	$-256M	$5M	$11M	$-13M	$-5M	$-571.0K	$-48M	$-4M	$15M	$67M
Taxes Paid	$0	$0	$6.0K	$-26.0K	$-674.0K	$139.0K	$26.0K	$267.0K	$180.0K	$197.0K	$90.0K	$-3M	$449.0K	$-521.0K	$3M	$6M
Free Cash Flow	·	$4M	·	·	·	$-15M	·	·	·	$-14M	·	·	·	$77M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-25M	·	·	·	$74M	·	·

Redditività 8

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	40.1%	51.2%	·	13.6%	·	·	·	·	·	·	·	·	·	·	·	·
Operating Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
Net Margin	-24.1%	-5.7%	·	-61.4%	-83.5%	-63.9%	·	-151.9%	-10.3%	-18.8%	·	-9.7%	-9.5%	-0.08%	·	23.2%
Pretax Margin	-42.4%	-9.9%	·	-108.5%	-156.4%	-112.5%	·	-269.4%	-23.1%	-34.9%	·	-30.8%	-19.4%	-5.7%	·	59.5%
EBITDA Margin	-29.3%	-3.3%	·	-98.6%	-139.8%	-104.9%	·	-259.4%	-13.0%	-29.4%	·	-23.1%	-16.9%	3.2%	·	61.1%
ROA	-1.7%	-0.45%	·	-2.4%	-3.4%	-2.5%	·	-5.6%	-0.41%	-0.64%	·	-0.29%	-0.29%	0.00%	·	2.1%
ROE	-5.3%	-1.5%	·	-8.6%	-11.3%	-8.4%	·	-22.9%	-1.6%	-2.6%	·	-1.3%	-1.3%	-0.01%	·	11.0%
ROIC	-4.3%	-0.47%	·	-7.6%	-11.2%	-8.3%	·	-19.5%	-0.85%	-2.0%	·	-1.1%	-0.99%	0.07%	·	9.9%

Liquidità e Solvibilità 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	4.1	5.9	·	5.3	5.2	6.0	·	10.7	10.0	11.3	·	9.0	9.3	6.1	·	7.2
Quick Ratio	2.6	4.7	·	4.3	4.3	5.0	·	9.6	8.9	10.1	·	8.0	8.4	5.5	·	6.3
Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
LT Debt / Equity	0.7	1.1	·	1.2	1.1	1.0	·	1.5	1.2	1.3	·	1.0	1.0	1.0	·	1.0
Interest Coverage	·	·	·	·	·	·	·	-12.4	-0.8	-1.7	·	-1.3	-1.7	0.2	·	37.3

Efficienza 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.1
Inventory Turnover	0.7	0.7	·	0.8	0.8	0.8	·	0.7	0.8	0.7	·	0.7	0.8	0.6	·	0.6
Receivables Turnover	1.7	2.1	·	1.6	1.4	1.4	·	1.7	1.7	1.4	·	0.8	0.8	0.9	·	2.1

Per Azione 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue / Share	$0.35	$0.45	·	$0.29	$0.33	$0.33	·	$0.46	$0.54	$0.48	·	$0.51	$0.52	$0.60	·	$1.45
Cash Flow / Share	·	$0.06	·	·	·	$-0.07	·	·	·	$-0.06	·	·	·	$0.65	·	·
EPS (TTM)	$-0.52	$-0.71	·	$-0.87	$-1.37	$-1.17	·	$-1.64	$-1.01	$-0.99	·	$0.20	$0.59	$1.17	·	$1.81

Valutazione (TTM) 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$209M	$205M	·	$192M	$220M	$242M	·	$277M	$275M	$274M	·	$420M	$544M	$718M	·	$907M
Net Income TTM	$-77M	$-105M	·	$-121M	$-193M	$-163M	·	$-225M	$-134M	$-131M	·	$25M	$75M	$153M	·	$238M
P/E	-12.0	-4.0	·	-3.3	-1.8	-1.9	·	-5.1	-7.1	-8.8	·	50.0	21.1	12.0	·	14.1
Earnings Yield	-8.3%	-25.1%	·	-30.3%	-56.9%	-52.9%	·	-19.7%	-14.1%	-11.4%	·	2.0%	4.8%	8.3%	·	7.1%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Ricavi	$186M	$259M	·	·	$289M
Margine Lordo %	18.3%	·	·	·	·
Margine Operativo %	-115.9%	-90.9%	·	·	-10.9%
Utile netto	$-131M	$-145M	·	·	$-119M
EPS Diluito	$-0.90	$-1.05	·	·	$-0.90

Metrica	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Debito / Patrimonio Netto	1.4	0.9	·	·	1.3
Rapporto corrente	6.6	7.5	·	·	8.0
Quick Ratio	5.4	6.3	·	·	7.2

Metrica	2025-12-31	2024-12-31	2024-09-30	2024-06-30	2023-12-31
Flusso di cassa libero	$-71M	$-22M	·	·	$61M

Proprietari istituzionali (13F) 197 filer · $904.1M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 197

Valore detenuto $904.1M

Nuove posizioni 45

Posizioni chiuse 24

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
45 (+16 vs trimestre precedente)	24 (+1 vs trimestre precedente)	56 (+2 vs trimestre precedente)	59 (+6 vs trimestre precedente)	+19.0M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
GTCR LLC	$125.736.031	20.150.005	13,91%	Azioni
BlackRock, Inc.	$62.217.666	9.970.780	6,88%	Azioni
BRAIDWELL LP	$54.306.227	8.702.921	6,01%	Azioni
12 West Capital Management LP	$44.055.617	7.060.195	4,87%	Azioni
MILLENNIUM MANAGEMENT LLC	$40.611.293	6.508.220	4,49%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$32.970.070	5.283.665	3,65%	Azioni
Ophir Asset Management Pty Ltd	$30.118.596	4.826.698	3,33%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$28.744.504	4.606.491	3,18%	Azioni
DEUTSCHE BANK AG\	$26.862.744	4.304.927	2,97%	Azioni
VANGUARD GROUP INC	$23.291.216	7.166.528	2,58%	Azioni
First Eagle Investment Management, LLC	$22.908.831	3.671.287	2,53%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$19.538.266	3.130.258	2,16%	Azioni
STATE STREET CORP	$18.106.645	2.901.706	2,00%	Azioni
Nuveen, LLC	$17.831.299	2.857.580	1,97%	Azioni
JPMORGAN CHASE & CO	$16.572.842	2.593.559	1,83%	Azioni
TWO SIGMA INVESTMENTS, LP	$14.076.317	2.255.820	1,56%	Azioni
Monaco Asset Management SAM	$13.921.602	2.231.026	1,54%	Azioni
PRUDENTIAL FINANCIAL INC	$13.429.441	2.152.154	1,49%	Azioni
CITADEL ADVISORS LLC	$13.245.011	2.122.598	1,47%	Azioni
Point72 Asset Management, L.P.	$12.514.813	2.005.579	1,38%	Azioni
MORGAN STANLEY	$11.907.642	1.908.276	1,32%	Azioni
Philosophy Capital Management LLC	$11.856.000	1.900.000	1,31%	Azioni
TUDOR INVESTMENT CORP ET AL	$11.538.253	1.849.079	1,28%	Azioni
ROYCE & ASSOCIATES LP	$11.284.716	1.808.448	1,25%	Azioni
GENERAL AMERICAN INVESTORS CO INC	$10.709.044	1.716.193	1,18%	Azioni
Hillsdale Investment Management Inc.	$10.501.159	1.682.878	1,16%	Azioni
SYSTEMATIC FINANCIAL MANAGEMENT LP	$10.394.704	1.665.817	1,15%	Azioni
GOLDMAN SACHS GROUP INC	$10.241.693	1.641.297	1,13%	Azioni
Tejara Capital Ltd	$9.954.953	1.595.345	1,10%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$9.444.901	1.513.606	1,04%	Azioni
MARSHALL WACE, LLP	$9.182.019	1.471.477	1,02%	Azioni
DIMENSIONAL FUND ADVISORS LP	$8.497.695	1.361.558	0,94%	Azioni
ArrowMark Colorado Holdings LLC	$7.956.000	1.275.000	0,88%	Azioni
Point72 (DIFC) Ltd	$7.430.106	2.588.887	0,82%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$6.910.045	1.107.379	0,76%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$6.686.385	1.071.536	0,74%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$6.417.085	1.028.379	0,71%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$6.290.588	1.008.107	0,70%	Azioni
NORTHERN TRUST CORP	$6.242.247	1.000.360	0,69%	Azioni
First Pacific Advisors, LP	$5.521.670	884.883	0,61%	Azioni
VANGUARD FIDUCIARY TRUST CO	$5.136.263	823.119	0,57%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$4.948.083	792.962	0,55%	Azioni
Verition Fund Management LLC	$4.853.085	777.738	0,54%	Azioni
Qube Research & Technologies Ltd	$4.670.309	748.447	0,52%	Azioni
Decker Retirement Planning Inc.	$3.849.337	616.881	0,43%	Azioni
Invesco Ltd.	$3.570.279	572.160	0,39%	Azioni
NORGES BANK	$3.540.576	567.400	0,39%	Azioni
BANK OF AMERICA CORP /DE/	$3.304.379	529.548	0,37%	Azioni
Cerity Partners LLC	$2.928.800	469.359	0,32%	Azioni
TWO SIGMA ADVISERS, LP	$2.849.275	876.700	0,32%	Azioni

Mostra tutti i 197 proprietari istituzionali →

Insider aziendali 25 insider · 13 dirigenti · 13 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Bernd Brust	Chief Executive Officer	08 Settembre 2026 F	1.561.249	3	0	$1.511.699
William E. Martin III	Chief Executive Officer	17 Marzo 2025 A	1.814.643	0	0	$0
Rajesh Asarpota	Chief Financial Officer	30 Settembre 2026 F	418.021	0	0	$0
Kevin Herde	Chief Financial Officer	15 Maggio 2025 A	674.636	0	0	$0
Andrew Burch	Former President, Nucleic Acid Production	15 Gennaio 2025 F	369.183	0	0	$0
Eric Tardif	President	19 Novembre 2020 A	·	0	0	$0
Brian Neel	Chief Operating Officer, Nucleic Acid Production	15 Febbraio 2023 F	16.473	0	0	$0
Lisa Sellers	Chief Operating Officer, Protein Detection	24 Novembre 2020 P	18.888	0	0	$0
Kurt Oreshack	General Counsel	10 Giugno 2026 S	335.767	0	2	$-254.000
Christine Dolan	Executive Vice President & General Manager, Cygnus Technologies	15 Maggio 2026 A	425.318	0	0	$0
Peter Michael Leddy	Chief Administrative Officer	15 Luglio 2025 F	727.177	0	0	$0
Rebecca Buzzeo	Chief Commercial Officer	17 Marzo 2025 A	606.791	0	0	$0
Carl Hull	Executive Chairman	11 Novembre 2024 P	175.000	0	0	$0
Gregory T Lucier	Direttore	09 Giugno 2026 G	156.077	2	0	$368.544
Susannah Gray	Direttore	26 Maggio 2026 A	216.200	0	0	$0
Luke Joseph Marker	Direttore	26 Maggio 2026 A	184.348	0	0	$0
Sean Laurence Cunningham	Direttore	26 Maggio 2026 A	184.348	0	0	$0
John A Deford	Direttore	26 Maggio 2026 A	205.478	0	0	$0
Andrew R Eckert	Direttore	26 Maggio 2026 A	412.183	0	0	$0
Murali Prahalad	Direttore	16 Giugno 2025 A	154.607	0	0	$0
Benjamin James Daverman	Direttore	16 Giugno 2025 A	138.055	0	0	$0
Jessica Hopfield	Direttore	16 Giugno 2025 A	199.907	0	0	$0
Anat Ashkenazi	Direttore	23 Maggio 2024 A	60.768	0	0	$0
Robert B Hance	Direttore	19 Novembre 2021 A	26.123	0	0	$0
Constantine S Mihas	·	26 Maggio 2026 A	184.348	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 19 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IBBQ · Invesco Exchange-Traded Fund Trust …	0,07%	10.546 SH	01 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,05%	804.353 SH	11 Settembre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,05%	179.599 SH	02 Ottobre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	98.331 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,03%	2.915.565 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,02%	53.877 NS	31 Luglio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	649.581 SH	19 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,01%	285.768 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	1.454.980 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,01%	315.518 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,01%	7.056 SH	11 Settembre 2026	Giornaliero
DFSU · Dimensional ETF Trust	0,00%	8.779 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	10.921 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	209.371 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	30.689 SH	10 Settembre 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	14.388 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	3.706.103 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	8.106 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	1.068.761 SH	11 Settembre 2026	Giornaliero

MRVI Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $8.00 +1,3%

4 26,7% Acquisto forte

6 40,0% Compra

5 33,3% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

5 analisti · 2026-10-03

Target medio $7.60 -3,8%

Ora Prezzo attuale $7.90

Basso$7.00 Media$7.60 Alto$8.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
MRVI	·	-3.6	-28.3%	-70.4%	-48.6%	18.3%
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·
ALMR	·	·	·	·	·	·
FTRE	$1.61B	-1.6	1.0%	-36.2%	-171.1%	·
BLFS	·	-241.8	28.9%	·	·	·
PSNL	$816M	-8.7	-17.7%	-116.7%	-36.0%	·
AZTA	$1.32B	-23.5	3.5%	-9.4%	-3.3%	45.5%
CYRX	$479M	6.9	12.4%	44.4%	15.3%	47.1%

Ultime notizie Notizie recenti che menzionano questa società

23

Maravai (MRVI) Trascrizione degli utili del Q1 2026 Yahoo Finance · 4 mesi, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

MRVI Classe A Maravai LifeSciences Holdings, Inc. - Class A common stock